Skip to main content
Caplight Logo









Orbicle Bio

Orbicle Bio

Private
SeoulEnergy & Sustainabilityhttps://orbiclebio.com/

Last Round

Accelerator

Nov 7, 2024

Total Funding Raised

$470,000

Company Overview

Orbicle Bio is an agtech company that develops carbon-negative organic fertilizers using naturally-derived microbes to promote crop growth and replace synthetic fertilizers.

Sector

Energy & Sustainability

Verticals

Biotechnology, Circular Economy, Clean Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

microbial fertilizerbiofertilizeragritechcarbon-negative fertilizeragricultural biotechclimate-techsustainable agricultureregenerative agricultureag biotechclimate smart agriculturesoil healthcarbon farminggreenhouse gas reductionrice farmingsynthetic fertilizer alternative

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orbicle Bio Comparables

Compare Orbicle Bio with similar companies based on industry and business-model similarity.

Orbicle Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Manna Agribio
87%
Kula Bio
71%
Sinochem Holdings Corporation Ltd.
63%

Orbicle Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorNov 7, 2024
Pre SeedAug 13, 2024

Key People

Founding team and executive leadership

Taek Yoon Lee

Chief Executive Officer

Executive Team

Orbicle Bio Investors

Notable investors and investment history

Orbicle Bio investors
InvestorRounds
500 GlobalAccelerator, Pre Seed
Tech Incubator Program for StartupsAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 7, 2024

    $470K raised from 500 Global and TIPS.

  • Aug 13, 2024

    Led by 500 Global

Orbicle Bio Filings

Explore SEC and related filing metadata, where available.

Orbicle Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Orbicle Bio's valuation, stock price, and market status.

Is Orbicle Bio a public or private company?

Orbicle Bio is a private company.

What is the current stock price of Orbicle Bio?

Orbicle Bio is a private company, so its shares have no public market price. Caplight tracks Orbicle Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Orbicle Bio worth (valuation)?

Valuation information for Orbicle Bio is not publicly available.

Can I buy Orbicle Bio stock?

Orbicle Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Orbicle Bio's last funding round?

Orbicle Bio's most recent funding round was Accelerator on November 7, 2024.

Who are the main investors in Orbicle Bio?

Key investors in Orbicle Bio include 500 Global.

Will Orbicle Bio IPO soon?

No public IPO plans have been announced for Orbicle Bio.

How can I track Orbicle Bio secondary market activity?

Caplight tracks bids, offers, and trades in Orbicle Bio's shares on secondary markets.

Firmographic Details

HeadquartersSeoul
Employee Range1
Year Founded2024
Last FundingNov 7, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?